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Abstract 
The title compounds 6a–j, 2-[(6-methyl-1,3-benzothiazol-2-yl)amino]-N- 
[2-(substituted phenyl/furan-2-yl)-4-oxo-1,3-thiazolidin-3-yl]nicotinamides, were 
prepared from 2-chloropyridine-3-carboxylic acid (1) and 2-amino-6-methyl-
benzothiazole (2) by known methods. All the compounds have been established 
by IR, 
1H NMR, 
13C NMR and elemental analyses. The in vitro antimicrobial 
screening of the compounds were carried out against two Gram positive (S. 
aureus, S. pyogenes), two Gram negative (E. coli, P. aeruginosa) bacteria and 
three fungal species (C. albicans,  A. niger,  A. clavatus) using the broth 
microdilution method. Some of the compounds are comparable with standard 
drugs. 
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Introduction 
A large number of drugs and biologically relevant molecules contain heterocyclic systems. 
Often the presence of hetero atoms or groupings imparts preferential specificities in their 
biological responses. The chemistry and biological study of heterocyclic compounds has 
been interesting field for a long time due to medicinal and agricultural reasons. The 
number of heterocyclic derivatives containing nitrogen and sulfur atom possess broad 754  N. B. Patel and F. M. Shaikh:   
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spectrum of biological activities. One of the most important heterocycle in medicinal 
chemistry is pyridine with wide application including antimicrobial, anti-inflammatory, anti-
HIV, antiplasmodial, anti-tubercular, antibacterial and anticonvulsant [1–7] activities, and 








































Sch. 1.   Reagents and conditions: (a) Ullmann condensation, Cu-Bronze, anhydrous 
K2CO3, DMF, reflux 5 h; (b) (i) SOCl2 and (ii) NH2NH2⋅H2O in CHCl3; (c) 
substituted aromatic aldehydes, DMF, reflux 5–6 h; (d) HSCH2COOH, 
anhydrous ZnCl2, 1,4-dioxane 12–14 h. 
a: R=H;  
b: R=2-Cl;  
c: R=4-Cl;  
d: R=2-NO2;  
e: R=3-NO2;  
f: R= 4-OH;  
g: R=4-OMe;  
h: R=3-OMe-4-OH;  
i: R=3-OMe-4-OH-5-NO2;  
j: R=2-furyl   New 4-Thiazolidinones of Nicotinic Acid with 2-Amino-6-methylbenzothiazole and their Biological … 755 
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The 4-thiazolidinone ring system comprises the broad spectrum for a number of 
biologically active compounds. In recent years, 4-thiazolidinones are the most extensively 
investigated class of compounds, which exhibit various biological activities, such as 
antimicrobial, anti-inflammatory, anti-HIV, anti-toxoplasma gondii and analgesic [8–12].  
Looking towards literature, it was thought that incorporation of all these biologically active 
moieties might be result in better antimicrobial activity and therefore as the part of our 
continuous research in developing the new heterocycles containing nitrogen and sulfur 
atom and screening their microbial studies [13–15], herewith we have designed 
4-thiazolidinones incorporated nicotinic acid with 2-amino-6-methylbenzothiazole and 
examined their antimicrobial activities.  
Results and Discussion 
Synthesis of compounds 
2-Chloro pyridine-3-carboxylic acid 1 and 2-amino-6-methyl benzothiazole 2 in presence of 
anhydrous K2CO3 and Cu-bronze in DMF solvent on Ullmann condensation yielded 
2-[(6-methyl-2-benzothiazolyl)amino]nicotinic acid (3). Further heating 3 with SOCl2 and 
subsequent reaction with hydrazine hydrate in chloroform formed 4 which on condensation 
with substituted aromatic aldehydes in DMF gave 5a–j. Thaizolidinones 6a–j were 
synthesized by refluxing 5a–j and thioglycolic acid in dry 1,4-dioxane for 12–14 h using a 
Dean-Stark apparatus (Scheme 1). Purity of the compounds was checked by TLC using 




Investigations, Results and Discussion 
The in vitro antibacterial and antifungal activities of the compounds are shown in Table 1. 
The MICs (μg/ml) were carried out by broth microdilution method as described by Rattan 
[17]. 
Antibacterial Activity 
From the screening results (Table 1), it is evident that compound 1 displayed good to 
moderate activity against all bacteria (150–250 μg/ml). 2-Amino-6-methylbenzothiazole (2), 
compound 3 and hydrazide 4 exhibited moderate to poor activity against all bacteria. 
The result shows that compounds 5a, 5e, 5j,  6d,  6g and 6j exhibited good activity   
(25–100 μg/ml) against E. coli; 5d, 5j, 6d, 6i and 6j exhibited good activity (50–100 μg/ml) 
against P. aeruginosa; 5a, 5e, 5f, 5h, 5j, 6d, 6b and 6j showed good to very good activity 
(25–150 μg/ml) against S. aureus; whereas 5b, 5h, 5j, 6c, 6i and 6j showed good activity 
(62.5–100  μg/ml) against S. pyogenes compared with ampicillin. All other compounds 
showed moderate activity. 
Antifungal Activity  
From the results of the antifungal activity (Table 1), it is evident that compounds 1, 2, 3 
and 4 showed good to moderate activity against C. albicans. 756  N. B. Patel and F. M. Shaikh:   
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Results also show that Schiff bases and 4-thiazolidinones possessed good activity against 
C. albicans while moderate activity against A. niger and A. clavatus. Compounds 5a, 5d, 
5g, 5j, 6b, 6e, 6f and 6j showed better activity (100–500 μg/ml) against C. albicans when 
compared with griseofulvin, while all compounds showed poor to moderate activity against 
A. niger and A. clavatus. 
Tab. 1.   Antibacterial and antifungal activities of 5a–j and 6a–j 
Minimal bactericidal concentration μg/ml
Gram negative  Gram positive 
Minimal fungicidal  
concentration μg/ml  Comp. 
E. coli  P. aerug. S. aureus S. pyogenus C. albicans  A. niger A. clavatus
1  150 150  200  250  250  500  500 
2  250 125  500  1000  1000  1000  1000 
3  500 1000  500  1000  500  250  250 
4  500 500  150  200  250  1000  1000 
5a  100 500  150  200  100  500  500 
5b  500 500  500  100  1000  1000 >1000 
5c  500 500  1000  1000  1000 >1000  >1000 
5d  250 62.5  500  500  250  1000  1000 
5e  62.5 150  100  200  1000  500  500 
5f  200 250  150  250  1000  1000  1000 
5g  250 500  500  1000  150  500  500 
5h  200 200  62.5  62.5  >1000  >1000  >1000 
5i  500 500  500  500  >1000  500  >1000 
5j  25 50  50  62.5  100  500  500 
6a  250 250  500  500  1000  1000  1000 
6b  500 500  150  500  150  1000  1000 
6c  500 1000  1000  100  >1000 >1000 >1000 
6d  50 100  100  150  >1000  1000  500 
6e  250 250  500  500  500  >1000  >1000 
6f  250 250  500  500  250  500  >1000 
6g  62.5 200  500  500  1000 >1000  500 
6h  200 500  500  500  1000  1000  1000 
6i  500 100  1000  100  >1000  500  >1000 
6j  100 62.5  25  100  500  1000  1000 
Ampicillin  100 100  250  100  –  –  – 
Griseofulvin  – –  –  –  500  100  100 
 
Conclusion 
Most of the compounds are comparable with ampicillin. Compounds bearing –Cl, –NO2 
groups and furan nucleus are more active than the remaining compounds. Compounds 5a, 
5d, 5g, 5j, 6b, 6e, 6f and 6j were found to be active against C. albicans but they found 
poor with other fungal species.  
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Experimental 
All chemicals were of analytical grade and used directly. Melting points of the synthesized 
compounds were determined by open tube capillary method and were uncorrected. The 
purity of the compounds was checked by TLC using Merck silica gel 60 F254. IR spectra 
were recorded on a Perkin-Elmer RX 1 FTIR spectrophotometer, using potassium bromide 
pellets; the frequencies are expressed in cm
−1. The 
1H NMR and 
13C NMR spectra were 
recorded with a Bruker Avance II 400 NMR spectrometer, using TMS as an internal 
reference, with DMSO-d6 as solvent. The chemical shifts are reported in parts per million 
(δ ppm). Elemental analyses were performed on Carlo Erba 1180 CHN analyzer. All the 
results of elemental analyses were in an acceptable error range. 
2-Amino-6-methylbenzothiazole (2), 2-[(6-methyl-1,3-benzothiazol-2-yl)amino]nicotinic acid 
(3) and 2-[(6-methyl-1,3-benzothiazol-2-yl)amino]nicotinohydrazide (4) were prepared by 
reported procedures [15, 16]. 
General procedure for syntheses of substituted N'-benzylidene/(2-furylmethylene)-
2-[(6-methyl-1,3-benzothiazol-2-yl)amino]nicotinohydrazides (5a–j) 
Benzaldehyde (0.012 mole, 1.272 g) and 3–4 drops of glacial acetic acid were added to a 
solution of 4 (0.01 mole, 3.0 g) in DMF (30 mL). The reaction mixture was refluxed for  
5–6 h and monitored by TLC on silica gel using ethyl acetate:toluene (1:3). The reaction 
mass was cooled and poured onto crushed ice and thus the separated solid was isolated, 
washed with water and recrystallized from ethanol to give 5a. Other derivatives 5b–j were 
prepared by the same method. 
   
Fig. 1.   Numbering of substituted N'-benzylidene/(2-furylmethylene)-2-[(6-methyl-1,3-
benzothiazol-2-yl)amino]nicotinohydrazides 5a–j 
N'-Benzylidene-2-[(6-methyl-1,3-benzothiazol-2-yl)amino]pyridine-3-carbohydrazide (5a) 
White solid, yield: 52 %, mp: 180–182 °C. IR (KBr) ν cm
−1: 3328 (NH), 1645 (amide-I), 
1554 (amide-II), 1224 (Amide-III), 1616 (C=N of Schiff base), 2872, 2945 (CH3). 
1H NMR 
(400 MHz, DMSO-d6, TMS): δ 1.25 (s, 3H, H-16), 5.84 (s, 1H, H-8), 6.81-8.58 (m, 11H, H-
4,5,6,11,13,14,19,20,21,22,23), 8.84 (s, 1H, H-7), 9.34 (s, 1H, H-17); 
13C NMR (100MHz, 
DMSO-d6, TMS): δ 22.1 (C-16), 112.6 (C-3), 118.3 (C-14), 119.8 (C-5), 122.4 (C-11), 
127.0 (C-13), 127.9 (C-20,22), 129.9 (C-19,23), 130.9 (C-10), 132.1 (C-21), 134.6 (C-18), 
136.9 (C-4), 138.4 (C-12), 143.3 (C-8), 148.2 (C-6), 151.3 (C-15), 161.5 (C-2), 162.1 (C-7), 758  N. B. Patel and F. M. Shaikh:   
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170.5 (C-9). Anal. Calcd. for C21H17N5OS: C, 65.10; H, 4.43; N, 18.09. Found: C, 65.05; H, 
4.38; N, 18.01. 
N'-(2-Chlorobenzylidene)-2-[(6-methyl-1,3-benzothiazol-2-yl)amino]pyridine-
3-carbohydrazide (5b) 
White solid, yield: 49 %, mp: 168–169 °C. IR (KBr) ν cm
−1: 3321 (NH), 1648 (amide-I), 
1552 (amide-II), 1223 (amide-III), 1614 (C=N of Schiff base), 2869, 2942 (CH3). 
1H NMR 
(400 MHz, DMSO-d6, TMS): 1.26 (s, 3H, H-16), 5.81 (s, 1H, H-8), 6.81-8.56 (m, 10H, H-
4,5,6,11,13,14,19,20,21,22), 8.87 (s, 1H, H-7), 9.36 (s, 1H, H-17). 
13C NMR (100MHz, 
DMSO-d6, TMS): δ 22.3 (C-16), 112.1 (C-3), 118.3 (C-14), 119.6 (C-5), 121.9 (C-11), 
126.9 (C-13), 127.1 (C-20), 127.9 (C-19), 130.4 (C-22), 130.8 (C-10), 132.3 (C-21), 133.5 
(C-23), 134.9 (C-18), 136.7 (C-4), 137.9 (C-12), 143.5 (C-8), 148.1 (C-6), 150.9 (C-15), 
161.7 (C-2), 162.3 (C-7), 170.1 (C-9). Anal. Calcd. for C21H16ClN5OS: C, 59.85; H, 3.83; N, 
16.63. Found: C, 59.78; H, 3.75; N, 16.56. 
N'-(4-Chlorobenzylidene)-2-[(6-methyl-1,3-benzothiazol-2-yl)amino]pyridine-
3-carbohydrazide (5c) 
White solid, yield: 56 %, mp: 156–158 °C. IR (KBr) ν cm
−1: 3319 (NH), 1642 (amide-I), 
1552 (amide-II), 1223 (amide-III), 1619 (C=N of Schiff base), 2867, 2941 (CH3). 
1H NMR 
(400 MHz, DMSO-d6, TMS): δ 1.24 (s, 3H, H-16), 5.82 (s, 1H, H-8), 6.79-8.53 (m, 10H, H-
4,5,6,11,13,14,19,20,22,23), 8.86 (s, 1H, H-7), 9.38 (s, 1H, H-17). 
13C NMR (100MHz, 
DMSO-d6, TMS): δ 1.25 (s, 3H, H-16), 5.84 (s, 1H, H-8), 6.81-8.58 (m, 11H, H-
4,5,6,11,13,14,19,20,21,22,23), 8.84 (s, 1H, H-7), 9.34 (s, 1H, H-17); 
13C NMR (100MHz, 
DMSO-d6, TMS): δ 22.5 (C-16), 112.8 (C-3), 118.1 (C-14), 119.9 (C-5), 122.1 (C-11), 
126.4 (C-13), 128.4 (C-20,22), 130.3 (C-19,23), 131.0 (C-10), 133.9 (C-18), 135.7 (C-21), 
137.1 (C-4), 138.3 (C-12), 144.1 (C-8), 147.9 (C-6), 151.1 (C-15), 161.9 (C-2), 163.5 (C-7), 
170.4 (C-9). Anal. Calcd. for C21H16ClN5OS: C, 59.85; H, 3.83; N, 16.63. Found: C, 59.79; 
H, 3.77; N, 16.58. 
2-[(6-Methyl-1,3-benzothiazol-2-yl)amino]-N'-(2-nitrobenzylidene)pyridine-
3-carbohydrazide (5d) 
Yellow solid, yield: 58 %, mp: 188–190 °C. IR (KBr) ν cm
−1: 3322 (NH), 1640 (amide-I), 
1551 (amide-II), 1221 (amide-III), 1615 (C=N of Schiff base), 2872, 2940 (CH3), 1370, 
1512 (NO2). 
1H NMR (400 MHz, DMSO-d6, TMS): δ 1.23 (s, 3H, H-16), 5.81 (s, 1H, H-8), 
6.82-8.56 (m, 10H, H-4,5,6,11,13,14,19,20,21,22), 8.82 (s, 1H, H-7), 9.37 (s, 1H, H-17). 
13C NMR (100MHz, DMSO-d6, TMS): δ 22.7 (C-16), 112.7 (C-3), 118.3 (C-14), 119.6 (C-
5), 121.9 (C-11), 123.8 (C-22), 126.9 (C-13), 129.8 (C-19), 130.5 (C-10), 132.4 (C-21), 
133.9 (C-20), 133.1 (C-18), 137.1 (C-4), 137.9 (C-12), 143.4 (C-8), 147.2 (C-23), 147.4 (C-
6), 150.9 (C-15), 161.8 (C-2), 162.0 (C-7), 170.1 (C-9). Anal. Calcd. for C21H16N6O3S: C, 
58.32; H, 3.73; N, 19.44. Found: C, 58.26; H, 3.67; N, 19.38. 
2-[(6-Methyl-1,3-benzothiazol-2-yl)amino]-N'-(3-nitrobenzylidene)pyridine-
3-carbohydrazide (5e) 
Yellow solid, yield: 54 %, mp: 176–178 °C. IR (KBr) ν cm
−1: 3321 (NH), 1641 (amide-I), 
1552 (amide-II), 1226 (amide-III), 1617 (C=N of Schiff base), 2870, 2941 (CH3), 1369, 
1511 (NO2). 
1H NMR (400 MHz, DMSO-d6, TMS): δ 1.27 (s, 3H, H-16), 5.87 (s, 1H, H-8), 
6.83-8.56 (m, 10H, H-4,5,6,11,13,14,19,20,21,23), 8.89 (s, 1H, H-7), 9.37 (s, 1H, H-17).   New 4-Thiazolidinones of Nicotinic Acid with 2-Amino-6-methylbenzothiazole and their Biological … 759 
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13C NMR (100MHz, DMSO-d6, TMS): δ 22.5 (C-16), 112.6 (C-3), 118.3 (C-14), 119.7 (C-
5), 121.1 (C-11), 121.7 (C-23), 126.8 (C-13), 128.9 (C-20), 130.6 (C-10), 131.8 (C-21), 
132.9 (C-19), 134.1 (C-18), 137.2 (C-4), 137.8 (C-12), 143.1 (C-8), 147.1 (C-22), 147.1 (C-
6), 151.1 (C-15), 161.7 (C-2), 162.8 (C-7), 170.2 (C-9). Anal. Calcd. for C21H16N6O3S: C, 
58.32; H, 3.73; N, 19.44. Found: C, 58.26; H, 3.67; N, 19.38. 
N'-(4-Hydroxybenzylidene)-2-[(6-methyl-1,3-benzothiazol-2-yl)amino]pyridine-
3-carbohydrazide (5f) 
White solid, yield: 61 %, mp: 191–192 °C. IR (KBr) ν cm
−1: 3322 (NH), 1644 (amide-I), 
1548 (amide-II), 1223 (amide-III), 1618 (C=N of Schiff base), 2868, 2941 (CH3), 3502 
(OH). 
1H NMR (400 MHz, DMSO-d6, TMS): δ 1.26 (s, 3H, H-16), 5.31 (s, 1H, H-24), 5.85 
(s, 1H, H-8), 6.82-8.54 (m, 10H, H-4,5,6,11,13,14,19,20,22,23), 8.79 (s, 1H, H-7), 9.31 (s, 
1H, H-17). 
13C NMR (100MHz, DMSO-d6, TMS): δ 1.25 (s, 3H, H-16), 5.84 (s, 1H, H-8), 
6.81-8.58 (m, 11H, H-4,5,6,11,13,14,19,20,21,22,23), 8.84 (s, 1H, H-7), 9.34 (s, 1H, H-17); 
13C NMR (100MHz, DMSO-d6, TMS): δ 22.6 (C-16), 112.4 (C-3), 117.9 (C-20,22), 118.3 
(C-14), 119.8 (C-5), 122.3 (C-11), 126.9 (C-13), 130.1 (C-19,23), 130.9 (C-10), 132.9 (C-
18), 136.9 (C-4), 138.1 (C-12), 143.2 (C-8), 147.9 (C-6), 151.3 (C-15), 161.6 (C-2), 158.1 
(C-21), 163.3 (C-7), 170.2 (C-9). Anal. Calcd. for C21H17N5O2S: C, 62.51; H, 4.25; N, 
17.37. Found: C, 62.45; H, 4.18; N, 17.30. 
N'-(4-Methoxybenzylidene)-2-[(6-methyl-1,3-benzothiazol-2-yl)amino]pyridine-
3-carbohydrazide (5g) 
Brown solid, yield: 59 %, mp: 170–171 °C. IR (KBr) ν cm
−1: 3321 (NH), 1643 (amide-I), 
1555 (amide-II), 1228 (amide-III), 1615 (C=N of Schiff base), 2873, 2939 (CH3), 1039, 
1179 (OCH3). 
1H NMR (400 MHz, DMSO-d6, TMS): δ 1.28 (s, 3H, H-16), 3.88 (s, 1H, H-
24), 5.81 (s, 1H, H-8), 6.86-8.58 (m, 10H, H-4,5,6,11,13,14,19,20,22,23), 8.86 (s, 1H, H-7), 
9.34 (s, 1H, H-17). 
13C NMR (100MHz, DMSO-d6, TMS): δ 21.9 (C-16), 55.1 (C-24), 113.1 
(C-3), 115.9 (C-20,22), 118.3 (C-14), 119.7 (C-5), 121.9 (C-11), 127.1 (C-13), 129.8 (C-
19,23), 131.0 (C-10), 131.9 (C-18), 136.9 (C-4), 137.1 (C-12), 142.9 (C-8), 148.0 (C-6), 
151.1 (C-15), 160.8 (C-2), 162.0 (C-21), 163.1 (C-7), 170.0 (C-9). Anal. Calcd. for 
C22H19N5O2S: C, 63.29; H, 4.59; N, 16.79. Found: C, 63.23; H, 4.50; N, 16.70. 
N'-(4-Hydroxy-3-methoxybenzylidene)-2-[(6-methyl-1,3-benzothiazol-2-yl)amino]pyridine-
3-carbohydrazide (5h) 
White solid, yield: 64 %, mp: 145–146 °C. IR (KBr) ν cm
−1: 3323 (NH), 1645 (amide-I), 
1554 (amide-II), 1221 (amide-III), 1616 (C=N of Schiff base), 2874, 2942 (CH3), 3507 
(OH). 
1H NMR (400 MHz, DMSO-d6, TMS): δ 1.26 (s, 3H, H-16), 3.86 (s, 3H, H-24), 5.38 
(s, 1H, H-25), 5.80 (s, 1H, H-8), 6.83-8.58 (m, 9H, H-4,5,6,11,13,14,19,20,23), 8.87 (s, 1H, 
H-7), 9.36 (s, 1H, H-17). 
13C NMR (100MHz, DMSO-d6, TMS): δ 22.2 (C-16), 55.9 (C-24), 
110.9 (C-23), 112.7 (C-3), 116.7 (C-20), 118.3 (C-14), 119.2 (C-5), 121.9 (C-11), 122.4 (C-
19), 127.0 (C-13), 130.9 (C-10), 132.1 (C-18), 137.4 (C-4), 138.1 (C-12), 143.1 (C-8), 
147.8 (C-6), 149.1 (C-22), 150.9 (C-15), 152.8 (C-21), 161.2 (C-2), 163.5 (C-7), 170.2 (C-
9). Anal. Calcd. for C22H19N5O3S: C, 60.95; H, 4.42; N, 16.17. Found: C, 60.88; H, 4.36; N, 
16.10. 
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N'-(4-Hydroxy-3-methoxy-5-nitrobenzylidene)-2-[(6-methyl-1,3-benzothiazol-
2-yl)amino]pyridine-3-carbohydrazide (5i) 
Yellow solid, yield: 48 %, mp: 198–199 °C. IR (KBr) ν cm
−1: 3324 (NH), 1647 (amide-I), 
1552 (amide-II), 1225 (amide-III), 1618 (C=N of Schiff base), 2871, 2939 (CH3), 1037, 
1181 (OCH3), 3503 (OH). 
1H NMR (400 MHz, DMSO-d6, TMS): δ 1.26 (s, 3H, H-16), 3.87 
(s, 3H, H-24), 5.32 (s, 1H, H-25), 5.84 (s, 1H, H-8), 6.82-8.56 (m, 8H, H-
4,5,6,11,13,14,19,23), 8.87 (s, 1H, H-7), 9.37 (s, 1H, H-17). 
13C NMR (100MHz, DMSO-d6, 
TMS): δ 22.5 (C-16), 55.7 (C-24), 112.6 (C-3), 117.4 (C-19), 118.0 (C-23), 118.3 (C-14), 
119.7 (C-5), 121.9 (C-11), 127.0 (C-13), 129.1 (C-18), 130.6 (C-10), 136.7 (C-20), 137.4 
(C-4), 138.2 (C-12), 140.8 (C-21), 143.3 (C-8), 147.7 (C-6), 150.5 (C-15), 151.7 (C-22), 
161.5 (C-2), 163.1 (C-7), 170.5 (C-9). Anal. Calcd. for C22H18N6O5S: C, 55.22; H, 3.79; N, 
17.57. Found: C, 55.16; H, 3.70; N, 17.50. 
N'-(Furan-2-ylmethylidene)-2-[(6-methyl-1,3-benzothiazol-2-yl)amino]pyridine-
3-carbohydrazide (5j) 
Black solid, yield: 54 %, mp: 181–184 °C, IR (KBr) ν cm
−1: 3320 (NH), 1646 (amide-I), 
1553 (amide-II), 1223 (amide-III), 1617 (C=N of Schiff base), 2869, 2941 (CH3). 
1H NMR 
(400 MHz, DMSO-d6, TMS): δ 1.27 (s, 3H, H-16), 5.81 (s, 1H, H-8), 6.86-8.52 (m, 9H, H-
4,5,6,11,13,14,19,20,21), 8.86 (s, 1H, H-7), 9.38 (s, 1H, H-17). 
13C NMR (100MHz, DMSO-
d6, TMS): δ 22.7 (C-16), 112.6 (C-3), 113.3 (C-20), 116.9 (C-14), 118.1(C-19), 119.8 (C-5), 
121.1 (C-11), 126.3 (C-13), 130.6 (C-10), 133.3 (C-8), 136.7 (C-4), 137.4 (C-12), 143.7 (C-
21), 147.2 (C-6), 148.4 (C-18), 150.3 (C-15), 161.5 (C-2), 162.7 (C-7), 170.2 (C-9). Anal. 
Calcd. for C19H15N5O2S: C, 60.46; H, 4.01; N, 18.57. Found: C, 60.39; H, 3.94; N, 18.50. 
General procedure for syntheses of 2-[(6-methyl-1,3-benzothiazol-2-yl)amino]-N-[2-
(substituted phenyl/furan-2-yl)-4-oxo-1,3-thiazolidin-3-yl]pyridine-3-carboxamides 
(6a–j) 
A mixture of 5a (0.01 mole, 3.87 g), thioglycolic acid (0.015 mole, 1.38 g) and a pinch of 
anhydrous ZnCl2 in dry 1,4-dioxane (30 mL) was refluxed for 12–14 h. The reaction was 
monitored by TLC on silica gel using ethyl acetate: toluene (1:3); was cooled and 
neutralized with 10% sodium bicarbonate solution. The solid product separated was 
filtered, washed with water and recrystallized from ethanol to give 6a. Similarly, other   
2-[(6-methyl-1,3-benzothiazol-2-yl)amino]-N-[2-(substituted phenyl/furan-2-yl)-4-oxo-1,3-
thiazolidin-3-yl]pyridine-3-carboxamides 6b–j have been prepared by the same method. 
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2-[(6-Methyl-1,3-benzothiazol-2-yl)amino]-N-(4-oxo-2-phenyl-1,3-thiazolidin-3-yl)pyridine-
3-carboxamide (6a) 
White solid, yield: 57 %, mp: 184–186 °C. IR (KBr) ν cm
−1: 3321 (NH), 1715 (C=O of 4-
thiazolidinone), 1646 (amide-I), 1556 (amide-II), 1224 (amide-III), 2878, 2950 (CH3). 
1H 
NMR (400 MHz, DMSO-d6, TMS): δ 1.24 (s, 3H, H-18), 3.63 (s, 2H, H-9), 6.21 (s, 1H, H-
10), 6.91-8.57 (m, 11H, H-4,5,6,13,15,16,21,22,23,24,25), 8.91 (s, 1H, H-7), 9.36 (s, 1H, 
H-19). 
13C NMR (100MHz, DMSO-d6, TMS): δ 21.1 (C-18), 35.9 (C-9), 57.7 (C-10), 111.6 
(C-3), 114.1 (C-16), 118.5 (C-5), 121.1 (C-13), 125.9 (C-15), 127.1 (C-22,24), 128.1 (C-
21,25), 129.9 (C-12), 134.4 (C-14), 137.0 (C-4), 138.1 (C-20), 147.4 (C-6), 149.1 (C-17), 
127.9 (C-23), 163.5 (C-2), 163.1 (C-7), 169.3 (C-8), 171.2 (C-11). Anal. Calcd. for 
C23H19N5O2S2: C, 59.86; H, 4.15; N, 15.18. Found: C, 59.80; H, 4.08; N, 15.12. 
N-[2-(2-Chlorophenyl)-4-oxo-1,3-thiazolidin-3-yl]-2-[(6-methyl-1,3-benzothiazol-
2-yl)amino]pyridine-3-carboxamide (6b) 
White solid, yield: 63 %, mp: 196–197 °C. IR (KBr) ν cm
−1: 3322 (NH), 1718 (C=O of 4-
thiazolidinone), 1644 (amide-I), 1555 (amide-II), 1225 (amide-III), 2875, 2948 (CH3), 755 
(C-Cl). 
1H NMR (400 MHz, DMSO-d6, TMS): δ 1.25 (s, 3H, H-18), 3.63 (s, 2H, H-9), 6.20 
(s, 1H, H-10), 6.89-8.58 (m, 10H, H-4,5,6,13,15,16,21,22,23,24), 8.93 (s, 1H, H-7), 9.33 (s, 
1H, H-19). 
13C NMR (100MHz, DMSO-d6, TMS): δ 23.7 (C-18), 35.7 (C-9), 57.8 (C-10), 
102.9 (C-20), 111.2 (C-3), 116.9 (C-16), 119.1 (C-5), 120.9 (C-13), 126.1 (C-15), 126.4 (C-
22), 127.9 (C-24), 128.4 (C-23), 129.9 (C-12), 130.1 (C-21), 133.8 (C-25), 134.4 (C-14), 
137.1 (C-4), 147.2 (C-6), 149.7 (C-17), 163.4 (C-7), 163.7 (C-2), 169.2 (C-8), 171.3 (C-11). 




White solid, yield: 60 %, mp: 209–210 °C. IR (KBr) ν cm
−1: 3323 (NH), 1716 (C=O of 4-
thiazolidinone), 1646 (amide-I), 1560 (amide-II), 1226 (amide-III), 2872, 2946 (CH3), 756 
(C-Cl). 
1H NMR (400 MHz, DMSO-d6, TMS): δ 1.23 (s, 3H, H-18), 3.65 (s, 2H, H-9), 6.26 
(s, 1H, H-10), 6.92-8.56 (m, 10H, H-4,5,6,13,15,16,21,22,24,25), 8.91 (s, 1H, H-7), 9.34 (s, 
1H, H-19). 
13C NMR (100MHz, DMSO-d6, TMS): δ 23.4 (C-18), 35.4 (C-9), 57.6 (C-10), 
111.4 (C-3), 116.9 (C-16), 118.4 (C-5), 121.1 (C-13), 125.9 (C-15), 127.6 (C-22,24), 129.2 
(C-21,25), 129.9 (C-12), 132.1 (C-23), 134.0 (C-14), 135.1 (C-20), 137.0 (C-4), 147.3 (C-
6), 150.1 (C-17),  163.2 (C-7),  163.8 (C-2),  169.7 (C-8), 171.0 (C-11). Anal. Calcd. for 
C23H18ClN5O2S2: C, 55.75; H, 3.66; N, 14.14. Found: C, 55.69; H, 3.61; N, 14.07. 
2-[(6-Methyl-1,3-benzothiazol-2-yl)amino]-N-[2-(2-nitrophenyl)-4-oxo-1,3-thiazolidin-
3-yl]pyridine-3-carboxamide (6d) 
Yellow solid, yield: 56 %, mp: 219–221 °C. IR (KBr) ν cm
−1: 3319 (NH), 1718 (C=O of 4-
thiazolidinone), 1644 (amide-I), 1554 (amide-II), 1224 (amide-III), 2871, 2945 (CH3), 1371, 
1514 (NO2). 
1H NMR (400 MHz, DMSO-d6, TMS): δ 1.25 (s, 3H, H-18), 3.62 (s, 2H, H-9), 
6.21 (s, 1H, H-10), 6.87-8.57 (m, 10H, H-4,5,6,13,15,16,21,22,23,24), 8.92 (s, 1H, H-7), 
9.35 (s, 1H, H-19). 
13C NMR (100MHz, DMSO-d6, TMS): δ 23.6 (C-18), 35.6 (C-9), 57.1 
(C-10), 111.3 (C-3), 116.5 (C-16), 118.7 (C-5), 120.9 (C-13), 124.1 (C-24), 125.9 (C-15), 
127.3 (C-23), 128.9 (C-21), 129.9 (C-12), 132.6 (C-22), 133.5 (C-20), 134.4 (C-14), 137.1 
(C-4), 147.3 (C-6), 148.6 (C-25), 149.8 (C-17), 163.1 (C-7), 163.6 (C-2), 169.4 (C-8), 171.1 762  N. B. Patel and F. M. Shaikh:   
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(C-11). Anal. Calcd. for C23H18N6O4S2: C, 54.54; H, 3.58; N, 16.60. Found: C, 54.48; H, 
3.50; N, 16.56. 
2-[(6-Methyl-1,3-benzothiazol-2-yl)amino]-N-[2-(3-nitrophenyl)-4-oxo-1,3-thiazolidin-
3-yl]pyridine-3-carboxamide (6e) 
Yellow solid, yield: 52 %, mp: 213–214 °C. IR (KBr) ν cm
−1: 3318 (NH), 1714 (C=O of 4-
thiazolidinone), 1648 (amide-I), 1560 (amide-II), 1227 (amide-III), 2869, 2946 (CH3), 1365, 
1510 (NO2). 
1H NMR (400 MHz, DMSO-d6, TMS): δ 1.21 (s, 3H, H-18), 3.60 (s, 2H, H-9), 
6.24 (s, 1H, H-10), 6.96-8.59 (m, 10H, H-4,5,6,13,15,16,21,22,23,25), 8.90 (s, 1H, H-7), 
9.34 (s, 1H, H-19). 
13C NMR (100MHz, DMSO-d6, TMS): δ 23.4 (C-18), 35.7 (C-9), 57.1 
(C-10), 111.3 (C-3), 116.5 (C-16), 119.1 (C-5), 121.2 (C-13), 122.1 (C-23), 123.6 (C-22), 
125.2 (C-25), 126.1 (C-15), 129.7 (C-12), 133.1 (C-21), 134.0 (C-14), 137.1 (C-4), 140.0 
(C-20), 146.4 (C-24), 147.9 (C-6), 149.7 (C-17), 163.1 (C-7), 163.4 (C-2), 169.2 (C-8), 
171.3 (C-11). Anal. Calcd. for C23H18N6O4S2: C, 54.54; H, 3.58; N, 16.60. Found: C, 54.47; 
H, 3.51; N, 16.55. 
N-[2-(4-Hydroxyphenyl)-4-oxo-1,3-thiazolidin-3-yl]-2-[(6-methyl-1,3-benzothiazol-
2-yl)amino]pyridine-3-carboxamide (6f) 
Brown solid, yield: 57 %, mp: 236–238 °C. IR (KBr) ν cm
−1: 3320 (NH), 1717 (C=O of 4-
thiazolidinone), 1646 (Aamide-I), 1556 (amide-II), 1228 (amide-III), 2872, 2942 (CH3), 
3506 (OH). 
1H NMR (400 MHz, DMSO-d6, TMS): δ 1.24 (s, 3H, H-18), 3.61 (s, 2H, H-9), 
5.30 (s, 1H, H-26), 6.19 (s, 1H, H-10), 6.86-8.52 (m, 10H, H-4,5,6,13,15,16,21,22,24,25), 
8.90 (s, 1H, H-7), 9.36 (s, 1H, H-19). 
13C NMR (100MHz, DMSO-d6, TMS): δ 23.2 (C-18), 
35.5 (C-9), 57.3 (C-10), 111.3 (C-3), 114.7 (C-16), 115.6 (C-22,24), 118.6 (C-5), 121.0 (C-
13), 125.9 (C-15), 129.8 (C-12), 130.3 (C-21,25), 131.6 (C-20), 134.3 (C-14), 136.9 (C-4), 
147.8 (C-6), 149.7 (C-17), 156.8 (C-23), 163.1 (C-2), 163.7 (C-7), 169.4 (C-8), 171.4 (C-




Brown solid, yield: 51 %, mp: 249–251 °C. IR (KBr) ν cm
−1: 3321 (NH), 1719 (C=O of 4-
thiazolidinone), 1648 (amide-I), 1552 (amide-II), 1227 (amide-III), 2873, 2947 (CH3), 1036, 
1189 (OCH3). 
1H NMR (400 MHz, DMSO-d6, TMS): δ 1.24 (s, 3H, H-18), 3.64 (s, 2H, H-9), 
3.82 (s, 3H, H-26), 6.23 (s, 1H, H-10), 6.93-8.55 (m, 10H, H-4,5,6,13,15,16,21,22,24,25), 
8.92 (s, 1H, H-7), 9.35 (s, 1H, H-19). 
13C NMR (100MHz, DMSO-d6, TMS): δ 21.7 (C-18), 
35.5 (C-9), 55.2 (C-26), 59.6 (C-10), 111.9 (C-3), 112.6 (C-22,24), 114.5 (C-16), 118.7 (C-
5), 120.9 (C-13), 125.8 (C-15), 128.9 (C-21,25), 129.8 (C-12), 130.9 (C-20), 134.4 (C-14), 
136.8 (C-4), 148.1 (C-6), 149.3 (C-17), 157.9 (C-23), 163.3 (C-2), 164.6 (C-7), 169.4 (C-8), 
171.5 (C-11). Anal. Calcd. for C24H21N5O3S2: C, 58.64; H, 4.34; N, 14.26. Found: C, 58.58; 
H, 4.29; N, 14.18. 
N-[2-(4-Hydroxy-3-methoxyphenyl)-4-oxo-1,3-thiazolidin-3-yl]-2-[(6-methyl-
1,3-benzothiazol-2-yl)amino]pyridine-3-carboxamide (6h) 
White solid, yield: 53 %, mp: 225–226 °C. IR (KBr) ν cm
−1: 3318 (NH), 1718 (C=O of 4-
thiazolidinone), 1647 (amide-I), 1556 (amide-II), 1224 (amide-III), 2876, 2944 (CH3), 1034, 
1191 (OCH3), 3510 (OH). 
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(s, 2H, H-9), 3.87 (s, 1H, H-26), 5.32 (s, 1H, H-27), 6.21 (s, 1H, H-10), 6.90-8.58 (m, 9H, 
H-4,5,6,13,15,16,21,22,25), 8.94 (s, 1H, H-7), 9.32 (s, 1H, H-19). 
13C NMR (100MHz, 
DMSO-d6, TMS): δ 23.8 (C-18), 35.4 (C-9), 55.9 (C-26), 57.6 (C-10), 111.1 (C-3), 114.1 
(C-25), 114.7 (C-16), 115.6 (C-22), 118.9 (C-5), 121.1 (C-13), 122.1 (C-21), 125.9 (C-15), 
130.1 (C-12), 131.8 (C-20), 134.1 (C-14), 137.1 (C-4), 146.9 (C-24), 147.2 (C-23), 147.9 
(C-6), 149.7 (C-17), 163.7 (C-2), 164.7 (C-7), 168.9 (C-8), 171.2 (C-11). Anal. Calcd. for 
C24H21N5O4S2: C, 56.79; H, 4.17; N, 13.81. Found: C, 56.71; H, 4.11; N, 13.73. 
N-[2-(4-Hydroxy-3-methoxy-5-nitrophenyl)-4-oxo-1,3-thiazolidin-3-yl]-2-[(6-methyl-
1,3-benzothiazol-2-yl)amino]pyridine-3-carboxamide (6i) 
Yellow solid, yield: 59 %, mp: 256-257 °C. IR (KBr) ν cm
−1: 3511 (OH), 3321 (NH), 1715 
(C=O of 4-thiazolidinone), 1646 (Amide-I), 1561 (Amide-II), 1226 (Amide-III), 2877, 2947 
(CH3), 1035, 1192 (OCH3). 
1H NMR (400 MHz, DMSO-d6, TMS): δ 1.23 (s, 3H, H-18), 3.62 
(s, 2H, H-9), 3.85 (s, 1H, H-26), 5.35 (s, 1H, H-27), 6.20 (s, 1H, H-10), 6.87-8.56 (m, 8H, 
H-4,5,6,13,15,16,21,25), 8.91 (s, 1H, H-7), 9.34 (s, 1H, H-19). 
13C NMR (100MHz, DMSO-
d6, TMS): δ 23.4 (C-18), 35.7 (C-9), 55.7 (C-26), 57.3 (C-10), 111.7 (C-3), 116.9 (C-16), 
118.8 (C-5,21), 120.2 (C-25), 121.1 (C-13), 125.9 (C-15), 130.1 (C-12), 132.9 (C-20), 
134.0 (C-14), 136.2 (C-23), 136.9 (C-4), 137.6 (C-22), 147.8 (C-6), 149.7 (C-17), 152.1 (C-
24), 163.5 (C-7), 163.8 (C-2), 169.7 (C-8), 171.6 (C-11). Anal. Calcd. for C24H20N6O6S2: C, 
52.17; H, 3.65; N, 15.22. Found: C, 52.10; H, 3.58; N, 15.15. 
N-[2-(Furan-2-yl)-4-oxo-1,3-thiazolidin-3-yl]-2-[(6-methyl-1,3-benzothiazol-
2-yl)amino]pyridine-3-carboxamide (6j) 
Black solid, yield: 59 %, mp: 223–225 °C. IR (KBr) ν cm
−1: 3419 (NH), 1715 (C=O of 4-
thiazolidinone), 1645 (amide-I), 1558 (amide-II), 1225 (amide-III), 2874, 2948 (CH3). 
1H 
NMR (400 MHz, DMSO-d6, TMS): δ 1.22 (s, 3H, H-18), 3.60 (s, 2H, H-9), 6.20 (s, 1H, H-
10), 6.78-8.51 (m, 9H, H-4,5,6,13,15,16,21,22,23), 8.91 (s, 1H, H-7), 9.34 (s, 1H, H-19). 
13C NMR (100MHz, DMSO-d6, TMS): δ 23.8 (C-18), 35.0 (C-9), 57.1 (C-10), 105.4 (C-
22),109.7 (C-21), 111.2 (C-3), 116.5 (C-16), 118.9 (C-5), 121.1 (C-13), 125.9 (C-15), 130.1 
(C-12), 134.0 (C-14), 137.0 (C-4), 141.5 (C-23), 147.3 (C-6), 149.7 (C-17), 151.1 (C-20), 
163.1 (C-2), 163.8 (C-7), 169.1 (C-8), 170.9 (C-11). Anal. Calcd. for C21H17N5O3S2: C, 
55.87; H, 3.80; N, 15.52. Found: C, 55.80; H, 3.72; N, 15.45. 
Experimental protocol for Antimicrobial activity 
All the compounds were tested for their antibacterial and antifungal activity (MIC) in vitro 
by broth dilution method against two Gram positive S. aureus MTCC 96, S. pyogenes 
MTCC 442 and two Gram negative E. coli MTCC 443, P. aeruginosa MTCC 741 bacteria 
and three fungal species C. albicans MTCC 227, A. niger MTCC 282 and A. clavatus 
MTCC 1323. Ampicillin for antibacterial activity while griseofulvin for antifungal activity 
were used as a standard drug 
The experimental protocol followed for antimicrobial activity was according to the same 
method as previously reported in literature [18, 19]. 
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